Create Account Sign In
The aim of cytoreduction in ovarian cancer surgery
ESGO eAcademy. Gultekin M. 03/22/18; 209137 Topic: Surgery
Disclosure(s): I have nothing to disclose
Prof. Dr. Murat Gultekin
Prof. Dr. Murat Gultekin
All contributions
Biography

Login now to access Premium content which is available to all ESGO members. 

If you're not yet an ESGO member, join ESGO and gain full access to eAcademy.

Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

Trending Content 

Adjuvant Therapy: Whom and How to Treat?
Concin N, Nout R, Matías-Guiú X. May 22, 2025
Oncogenetics in Focus: From Risk to Prevention in Women’s Cancers
Gultekin M, Grigore M, Marchetti C. Nov 11, 2025
Flowchart Frenzy: Simplifying GTD Management
Joneborg U, Seckl M, Braicu E, Lok C. Jun 17, 2025
HPV 360° - Innovations in Vaccination and Screening
Gultekin M, Rita Sousa S, Vorsters A. Jul 9, 2025
Metastatic and Recurrent Endometrial Cancer
Concin N, Nout R, Matías-Guiú X, Marth C. Jun 24, 2025
Beyond Survival: Psycho-Oncology, Resilience, Quality of Life and Sexuality after Cancer
Gultekin M, Hasenburg A, EL HAJJ H, Toth I. Sep 7, 2025
Trust Trial Debate
Braun C, Mahner S, Fotopoulou C. Jun 26, 2025
ENYGO Surgical Mentorship Webinar: Upper Abdominal Surgery in Ovarian Cancer
Fotopoulou C, Harter P, Taskiran C. Jun 26, 2025
EDI Leadership webinar - Thriving as a Surgeon in a Global Career
Richter Spritzer D, EL HAJJ H. Sep 15, 2025
EXPLORATORY LAPAROSCOPY FOR TUBOOVARIAN MALIGNANCY
Gertych W. Aug 7, 2025

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies